PARK8 Antibody

ProSci
Product Code: PSI-62-662
Product Group: Primary Antibodies
Supplier: ProSci
CodeSizePrice
PSI-62-662-400ul400ul£626.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Isotype: Rabbit Ig
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Human
Applications:
  • Immunohistochemistry- Paraffin Embedded (IHC-P)
  • Western Blot (WB)
Storage:
Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Images

1 / 3
Western blot analysis of PARK8 (LRRK2) using rabbit polyclonal PARK8 (LRRK2)Antibody (L899). (A) 293 cell lysate (2 ug) transiently transfected with the PARK8 gene. (B) Mouse brain lysates (35ug/lane). PARK8 was detected using the purified polyclonal antibody.
2 / 3
PARK8 (LRRK2)Antibody (L899) detect over-expressed human LRRK2 protein.
3 / 3

Western blot analysis of PARK8 (LRRK2) using rabbit polyclonal PARK8 (LRRK2)Antibody (L899). (A) 293 cell lysate (2 ug) transiently transfected with the PARK8 gene. (B) Mouse brain lysates (35ug/lane). PARK8 was detected using the purified polyclonal antibody.
PARK8 (LRRK2)Antibody (L899) detect over-expressed human LRRK2 protein.

Further Information

Additional Names:
Leucine-rich repeat serine/threonine-protein kinase 2, Dardarin, LRRK2, PARK8
Application Note:
For WB starting dilution is: 1:1000

For IHC-P starting dilution is: 1:50~100
Background:
Parkinson is the second most common neurodegenerative disease after Alzheimers. About 1 percent of people over the age of 65 and 3 percent of people over the age of 75 are affected by the disease. The mutation is the most common cause of Parkinson's disease identified to date. LRRK2, a genetic mutation, was recently found linked to about 5 percent of inherited cases of Parkinson's disease. By high-resolution recombination mapping and candidate gene sequencing in 46 families, 6 disease-segregating mutations (5 missense and 1 putative splice site mutation). It may be central to the pathogenesis of several major neurodegenerative disorders associated with parkinsonism. LRRK2 belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains.
Background References:
  • Shen J. Neuron. 2004. 44:575.
  • Paisan-Ruiz C, et al. Neuron. 2004. 44(4):595.
  • Zimprich A, et al. Neuron. 2004. 44(4):601.
  • Wszolek ZK, et al. Neurology. 2004. 62(9):1619.
Buffer:
Supplied in PBS with 0.09% (W/V) sodium azide.
Concentration:
batch dependent
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Immunogen:
This PARK8(LRRK2) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 931-962 amino acids from human PARK8(LRRK2).
NCBI Gene ID #:
120892
NCBI Official Name:
Leucine-rich repeat serine/threonine-protein kinase 2
NCBI Official Symbol:
LRRK2
NCBI Organism:
Homo sapiens
Physical State:
Liquid
PREDICTED MOLECULAR WEIGHT:
286 kDa
Protein Accession #:
Q5S007
Protein GI Number:
294862450
Purification:
This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis
Research Area:
Neuroscience,Autophagy
Swissprot #:
Q5S007
User NOte:
Optimal dilutions for each application to be determined by the researcher.